PT  - JOURNAL ARTICLE
AU  - Thomas Ash
AU  - Antonio M. Bento
AU  - Daniel Kaffine
AU  - Akhil Rao
AU  - Ana I. Bento
TI  - Disease-economy trade-offs under alternative pandemic control strategies
AID  - 10.1101/2021.02.12.21251599
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.02.12.21251599
4099  - http://medrxiv.org/content/early/2021/02/13/2021.02.12.21251599.short
4100  - http://medrxiv.org/content/early/2021/02/13/2021.02.12.21251599.full
AB  - Public policy and academic debates regarding pandemic control strategies note potential disease-economy trade-offs, and often prioritize one outcome over the other. Using a calibrated, coupled epi-economic model of individual behavior embedded within the broader economy during a novel epidemic, we show that targeted isolation strategies can avert up to 91% of individual economic losses relative to voluntary isolation strategies. Notably, the economic savings from targeted isolation strategies do not impose an additional disease burden, avoiding disease-economy trade-offs. In contrast, widely-used blanket lock-downs do create sharp disease-economy trade-offs and impose substantial economic costs per additional case avoided. These results highlight the benefits of targeted isolation strategies for disease control, as targeted isolation addresses the fundamental coordination failure between infectious and susceptible individuals that drives the recession. Our coupled-systems framework uses a data-driven approach to map economic activities to contacts, which facilitates developing effective control strategies for future novel pathogens. Implementation of this framework can help control disease spread and potentially avert trillions of dollars in losses.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo funding to reportAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:NAAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData and code for reproducibility will be available upon request. Will be available on a GitHub repository upon acceptance